Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

So-Called Rare Diseases Are Too Common to Ignore

Posted on June 19th, 2017 by in Pharma R&D

It’s time to re-think our attitude towards rare diseases. Even though relatively few people suffer from any given rare disease, there are so many of these maladies that it’s a surprisingly large swath of the population that is actually victimized by them. Continue reading “So-Called Rare Diseases Are Too Common to Ignore” »

Targeting Rare Diseases

Posted on March 20th, 2017 by in Pharma R&D

What is known as a “rare” disease might affect anywhere between a couple hundred to a couple hundred thousand people here in the U.S. And it’s estimated that as much as 10% of the nation’s population has one of the thousands of known rare diseases, most of which are genetic. Continue reading “Targeting Rare Diseases” »

Using Text Mining to Find Treatments for Rare Diseases

Posted on May 5th, 2016 by in Pharma R&D

When you compare PubMed search results for rare diseases, such as “congenital hyperinsulinism” (767), schwannomatosis (250) or “Mabry syndrome” (34), to that of “diabetes” (542,987), “heart attack” (217,694) or “obesity” (237,307), the disparity in attention becomes much more obvious. Continue reading “Using Text Mining to Find Treatments for Rare Diseases” »